Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

I-Flow Corp.

This article was originally published in The Gray Sheet

Executive Summary

Inks agreement with SoloPak Pharmaceuticals to distribute SideKick and Paragon ambulatory infusion systems and related disposables and accessories in the U.S. through Dec. 31, 1997. "The agreement provides for minimum purchase quotas for 1994, 1995 and the first half of 1996 which aggregate $16.9 mil.," I-Flow says in a release. Beginning July 1, 1996, SoloPak may purchase U.S. rights to the products for $8 mil. "If SoloPak does not exercise its option, the minimum purchases for the second half of 1996 and for 1997 will be substantially higher than those in the earlier period of the agreement," the firm notes

Latest Headlines
See All
UsernamePublicRestriction

Register

MT003153

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel